WEBINAR: A Pivotal Shift in Life Sciences Industry Across R&D and Commercial: A Conversation with the Experts

The life sciences pipeline is evolving from small molecules to biologics and cell and gene therapy, and there are currently more than 900 therapies in clinical trials. As competition rises, manufacturers also need to manage the reality that the cost of research and development has doubled as ROI reduces from 10% to 2%.

In this webinar discussion, EVERSANA’s Vikram Anand and Rohit Sood look at why the industry needs to reimagine medical affairs, regulatory affairs, quality control and pharmacovigilance for the sake of manufacturers and their patients, and how breaking industry silos is blazing new trails for launch success.

Watch the conversation now!

Meet with our experts.

Author
Rohit Sood
Executive Vice President, COMPLETE Commercialization

Rohit is helping EVERSANA disrupt the life sciences industry with innovative commercialization solutions. As a strategy and operations professional, he has served as both an advisor and global strategy leader, driving top-line business growth…

Vikram Anand
Executive Vice President, Compliance Services

Vikram’s experience includes more than 20 years of leading global teams and building successful partnerships with top life sciences companies and health authorities around the globe. He has a strong background in digital technology…